Author

Lujain Ez Eddin

Observed names: Eddin, Lujain Ez, Ez Eddin, Lujain

Institution: Western University

Observed institution: Western University

OpenAlex ID: A5115080645

β‐Blockers and risk of neuropsychiatric disorders: A systematic review and meta‐analysis

2024 · Lujain Ez Eddin, Rebecca Preyra, et al. · British Journal of Clinical Pharmacology · 25

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

2025 · Rebecca Preyra, Lujain Ez Eddin, et al. · British Journal of Clinical Pharmacology · 18

β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS

2025 · Lujain Ez Eddin, Mohammad Ali Omrani, et al. · Journal of Psychopharmacology · 10

Who is missing from SGLT-2 inhibitor trials? Implications for drug safety and generalizability: a systematic review and meta-analysis

2026 · Mohammad Ali Omrani, Bala Swetha Baskaran, et al. · Expert Opinion on Drug Safety

Who is missing from SGLT-2 inhibitor trials? Implications for drug safety and generalizability: a systematic review and meta-analysis

2026 · Omrani, Mohammad Ali, Baskaran, Bala Swetha, et al. · Figshare

Beyond disproportionality: systematic prioritization of actionable levothyroxine safety signals in FAERS

2026 · Bala Swetha Baskaran, Niaz Chalabianloo, et al. · Canadian Journal of Physiology and Pharmacology

β-Blockers and the Risk of Neuropsychiatric Adverse Events: A Multi-Method Approach

2025 · Ez Eddin, Lujain · Scholarship@Western (Western University)

Safety of sulfamethoxazole–trimethoprim for the treatment of bacterial infection in outpatient settings: A systematic review and meta‐analysis with active comparator disproportionality analysis

2025 · Rebecca Preyra, Lujain Ez Eddin, et al. · British Journal of Clinical Pharmacology

Works count: 11

Citation count: 53

H-index: 3

I10-index: 3